83 related articles for article (PubMed ID: 24798567)
1. Rituximab in immunologic glomerular diseases.
Ejaz AA; Asmar A; Alsabbagh MM; Ahsan N
MAbs; 2012; 4(2):198-207. PubMed ID: 22377738
[TBL] [Abstract][Full Text] [Related]
2. A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis.
Hartinger JM; Šíma M; Hrušková Z; Pilková A; Krátký V; Ryšavá R; Jančová E; Bobek D; Douša J; Francová I; Tesař V; Slanař O
Biomed Pharmacother; 2024 Jun; 175():116655. PubMed ID: 38678967
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic applications of monoclonal antibodies.
Berger M; Shankar V; Vafai A
Am J Med Sci; 2002 Jul; 324(1):14-30. PubMed ID: 12120821
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies for renal diseases: current concepts and ongoing treatments.
Santoro D; Pellicanò V; Visconti L; Trifirò G; Cernaro V; Buemi M
Expert Opin Biol Ther; 2015; 15(8):1119-43. PubMed ID: 26087994
[TBL] [Abstract][Full Text] [Related]
5. Treatment of C3 glomerulopathy with complement blockers.
Vivarelli M; Emma F
Semin Thromb Hemost; 2014 Jun; 40(4):472-7. PubMed ID: 24799307
[TBL] [Abstract][Full Text] [Related]
6. Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab.
Verhave JC; Wetzels JF; van de Kar NC
Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv131-41. PubMed ID: 25165180
[TBL] [Abstract][Full Text] [Related]
7. Genetics of atypical hemolytic uremic syndrome (aHUS).
Rodríguez de Córdoba S; Hidalgo MS; Pinto S; Tortajada A
Semin Thromb Hemost; 2014 Jun; 40(4):422-30. PubMed ID: 24799305
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic monoclonal antibody market.
Ecker DM; Jones SD; Levine HL
MAbs; 2015; 7(1):9-14. PubMed ID: 25529996
[TBL] [Abstract][Full Text] [Related]
9. Clinical advances in immunotherapy for immune-mediated glomerular diseases.
Tang B; Yang X
Clin Exp Med; 2023 Dec; 23(8):4091-4105. PubMed ID: 37889398
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Antibodies in Medicine.
Sharma P; Joshi RV; Pritchard R; Xu K; Eicher MA
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764213
[TBL] [Abstract][Full Text] [Related]
11. Contemporary Monoclonal Antibody Utilization in Glomerular Diseases.
Mansour I; Murugapandian S; Tanriover B; Thajudeen B
Mayo Clin Proc Innov Qual Outcomes; 2023 Aug; 7(4):276-290. PubMed ID: 37448529
[TBL] [Abstract][Full Text] [Related]
12. IL-20 in Acute Kidney Injury: Role in Pathogenesis and Potential as a Therapeutic Target.
Lin TY; Hsu YH
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32028746
[TBL] [Abstract][Full Text] [Related]
13. Rituximab Exhibits Altered Pharmacokinetics in Patients With Membranous Nephropathy.
Fogueri U; Cheungapasitporn W; Bourne D; Fervenza FC; Joy MS
Ann Pharmacother; 2019 Apr; 53(4):357-363. PubMed ID: 30293439
[TBL] [Abstract][Full Text] [Related]
14. Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence.
Sciascia S; Radin M; Yazdany J; Tektonidou M; Cecchi I; Roccatello D; Dall'Era M
Rheumatol Int; 2017 Aug; 37(8):1249-1255. PubMed ID: 28258475
[TBL] [Abstract][Full Text] [Related]
15. Rituximab therapy for primary glomerulonephritis: Report on two cases.
Fabrizi F; Cresseri D; Fogazzi GB; Moroni G; Passerini P; Martin P; Messa P
World J Clin Cases; 2015 Aug; 3(8):736-42. PubMed ID: 26301235
[TBL] [Abstract][Full Text] [Related]
16. Timing of eculizumab therapy for C3 glomerulonephritis.
Rodriguez-Osorio L; Ortiz A
Clin Kidney J; 2015 Aug; 8(4):449-52. PubMed ID: 26251715
[TBL] [Abstract][Full Text] [Related]
17. Role of monoclonal antibodies in the treatment of immune-mediated glomerular diseases.
Manrique J; Cravedi P
Nefrologia; 2014 May; 34(3):388-97. PubMed ID: 24798567
[TBL] [Abstract][Full Text] [Related]
18. [Role of monoclonal antibodies in the treatment of immune-mediated kidney disease: the state of the art].
Cravedi P
G Ital Nefrol; 2012; 29(3):274-82; discussion 292. PubMed ID: 22718450
[TBL] [Abstract][Full Text] [Related]
19. Rituximab-based novel strategies for the treatment of immune-mediated glomerular diseases.
Kattah AG; Fervenza FC; Roccatello D
Autoimmun Rev; 2013 Jun; 12(8):854-9. PubMed ID: 23000633
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
